Smith Susan Laura

3.2

3.2

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Y-mAbs Therapeutics, Inc (YMAB)

Transaction date 7 Mar 2025

Proposed sale

Price

138.93

Quantity 72,540

Value US$3,468,835

Y-mAbs Therapeutics, Inc (YMAB)

Transaction date 5 Mar 2024

Sale

Price

341.13

Quantity 74,007 -33.4%

Value US$2,132,383

Comments Filing

Y-mAbs Therapeutics, Inc (YMAB)

Transaction date 5 Mar 2024

Proposed sale

Price

281.65

Quantity 29,626

Value US$3,618,316

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-03-07	2025-03-07	Y-mAbs Therapeutics, Inc (YMAB)	PrS Proposed sale	72,540 138.93 US$3,468,835	72,540	138.93	US$3,468,835
2024-03-07	2024-03-05	Y-mAbs Therapeutics, Inc (YMAB)	S Sale	74,007 -33.4% 341.13 US$2,132,383	74,007 -33.4%	341.13	US$2,132,383
2024-03-06	2024-03-05	Y-mAbs Therapeutics, Inc (YMAB)	PrS Proposed sale	29,626 281.65 US$3,618,316	29,626	281.65	US$3,618,316